“Telomerase is not all bad. If it’s regulated properly, it helps to reduce the rate of cancer.”
Kan Cao, associate professor of cell biology and molecular genetics at the University of Maryland, who, along with NIH Director Francis Collins and National Institute of Aging Director Richard Hodes, is a co-corresponding author of a paper reporting the findings in the Proceedings of the National Academy of Sciences

“We also need to take advantage of those opportunities, and it is important to put on the table that Brazil can increase its participation in clinical trials. Compared to other parts of the world, we are really, really behind, and it all has to do with regulations.”
Carlos Murillo, country manager of Pfizer Inc. in Brazil, speaking at the annual BIO Latin America conference on the opportunities to undertake clinical trials in the country

“MRSA and antimicrobial resistance must immediately become a top global political priority.”
Jeanine Thomas, founder of MRSA Survivors Network and World MRSA Day

No Comments